Bayer’s medical skin creams draw suitors Lupin, BC Partners: sources
By Arno Schuetze, Pamela Barbaglia and Ludwig Burger FRANKFURT (Reuters) – Bayer has short-listed India's Lupin and investor BC Partners as prospective buyers of medical skin cream assets in a potential 1 billion euro ($1.1 billion) deal, several people familiar with the sale told Reuters. Germany&039;s Bayer has for more than two years sought to narrow the focus of its healthcare division and its planned $66 billion Monsanto takeover has added urgency to that drive. Bayer has, however, said a debt package and cash call would suffice to finance the Monsanto purchase, its largest ever transaction.
